Product References
New diagnostic markers in salivary gland tumors.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Schneider S,Kloimstein P,Pammer J,Brannath W,Grasl MCh,Erovic BM
MA1-37166 was used in immunohistochemistry to study the expresion of tumor antigens in order to identify novel diagnostic markers of parotid gland tumors
Tue Jul 01 00:00:00 EDT 2014
Biomarkers in advanced larynx cancer.
The Laryngoscope
Bradford CR,Kumar B,Bellile E,Lee J,Taylor J,D'Silva N,Cordell K,Kleer C,Kupfer R,Kumar P,Urba S,Worden F,Eisbruch A,Wolf GT,Teknos TN,Prince ME,Chepeha DB,Hogikyan ND,Moyer JS,Carey TE
MA1-37166 was used in immunohistochemistry to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx
Wed Jan 01 00:00:00 EST 2014
Identification of novel target proteins in sebaceous gland carcinoma.
Head & neck
Erovic BM,Al Habeeb A,Harris L,Goldstein DP,Kim D,Ghazarian D,Irish JC
MA1-37166 was used in immunohistochemistry to identify novel therapeutic target proteins in sebaceous gland carcinoma
Wed May 01 00:00:00 EDT 2013
Head and neck squamous cell carcinoma in pregnant women.
Head & neck
Eliassen AM,Hauff SJ,Tang AL,Thomas DH,McHugh JB,Walline HM,Stoerker J,Maxwell JH,Worden FP,Eisbruch A,Czerwinski MJ,Papagerakis SM,Chepeha DB,Bradford CR,Hanauer DA,Carey TE,Prince ME
MA1-37166 was used in immunohistochemistry to study oral cancer in pregnant women
Fri Mar 01 00:00:00 EST 2013
Prognostic and predictive markers in medullary thyroid carcinoma.
Endocrine pathology
Erovic BM,Kim D,Cassol C,Goldstein DP,Irish JC,Asa SL,Mete O
MA1-37166 was used in immunohistochemistry to identify markers with progniostic and predictive value in patients with medullary thyroid cancer
Sat Dec 01 00:00:00 EST 2012
Biomarkers of parathyroid carcinoma.
Endocrine pathology
Erovic BM,Harris L,Jamali M,Goldstein DP,Irish JC,Asa SL,Mete O
MA1-37166 was used in immunohistochemistry to establish a biomarker panel suitable for the identification of parathyroid carcinomas
Sat Dec 01 00:00:00 EST 2012
MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3.
The Journal of cell biology
Hirai H,Verma M,Watanabe S,Tastad C,Asakura Y,Asakura A
MA1-37166 was used in western blot to study the mechanism by which the MyoD regulates myoblast apoptosis
Mon Oct 18 00:00:00 EDT 2010
Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?
The Laryngoscope
Wildeman MA,Gibcus JH,Hauptmann M,Begg AC,van Velthuysen ML,Hoebers FJ,Mastik MF,Schuuring E,van der Wal JE,van den Brekel MW
MA1-37166 was used in immunohistochemistry to study the value of 13 immunohistochemical biomarkers in predicting response to radiotherapy in laryngeal cancer
Sun Feb 01 00:00:00 EST 2009
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer.
Archives of otolaryngology--head & neck surgery
Kumar B,Cordell KG,D'Silva N,Prince ME,Adams ME,Fisher SG,Wolf GT,Carey TE,Bradford CR
MA1-37166 was used in immunohistochemistry to examine the prognostic significance of p53 and Bcl-xL as predictive markers in advanced laryngeal cancer
Tue Apr 01 00:00:00 EDT 2008
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
International journal of radiation oncology, biology, physics
Bauer JA,Kumar B,Cordell KG,Prince ME,Tran HH,Wolf GT,Chepeha DB,Teknos TN,Wang S,Eisbruch A,Tsien CI,Urba SG,Worden FP,Lee J,Griffith KA,Taylor JM,D'Silva N,Wang SJ,Wolter KG,Henson B,Fisher SG,Carey TE,Bradford CR
MA1-37166 was used in immunohistochemistry to investigate the expression of Bcl-xL and p53 in cisplatin-resistant head and neck squamous cell cancers
Wed Nov 28 00:00:00 EST 2007
A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology
Mita MM,Ochoa L,Rowinsky EK,Kuhn J,Schwartz G,Hammond LA,Patnaik A,Yeh IT,Izbicka E,Berg K,Tolcher AW
MA1-37166 was used in immunohistochemistry to perform a phase I clinical study of oblimersen and irintecan in advanced metastatic colorectal cancer
Wed Feb 01 00:00:00 EST 2006
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer.
British journal of cancer
Nix P,Cawkwell L,Patmore H,Greenman J,Stafford N
MA1-37166 was used in immunohistochemistry to study the value of Bcl-2 expression in predicting the response to radiotherapy of laryngeal cancer patients
Mon Jun 20 00:00:00 EDT 2005